Targeted therapy in Liv Bona Dea Hospital Baku

Targeted therapy at Liv Bona Dea Hospital in Baku, Azerbaijan may cost around $6,750 per course. The JCI-accredited facility offers personalized cancer treatment based on genetic testing results. Patients receive a comprehensive package including consultations, PET-CT scans, and specialized genetic analysis.

Treatment Approach

The hospital provides targeted therapy for squamous cell carcinoma, neuroendocrine carcinoma, and adenocarcinoma. Treatment plans are customized after thorough genetic testing. Doctors evaluate tumor mutational burden (TMB) and specific mutations before recommending therapy.

Diagnostic Process

Patients undergo several tests before treatment begins. These include:

• Next-generation sequencing (NGS)
• PET-CT scan
• TMB evaluation
• Testing for MSI, BRAF, NTRK, KRAS, NRAS, and HER2 markers

Package Inclusions

The treatment package covers:

• Oncologist consultation ($100-$150)
• Pathology review
• PET-CT scan
• Genetic testing
• Airport transfers
• Accommodation arrangements
• Language interpretation

Hospital Features

Liv Bona Dea Hospital spans 37,500 sq.m with 156 beds. It maintains 28 intensive care units. The facility achieved 100% compliance with JCI standards in 2022.

Dr. Elxan Mammadov, a medical oncologist, leads the treatment team. The hospital reevaluates patient conditions after three months of therapy. Patients can inquire about personalized treatment plans based on their test results.